Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01184196 · ClinicalTrials.gov registry record · Phase 4
ChloraPrep Versus Betadine for Elective Knee Replacement Surgery
A Phase 4 study, sponsored by Central DuPage Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
NCT01184196 is a Phase 4 study that was terminated before completion, run by Central DuPage Hospital. The registered enrollment target is 55 participants.
The verdict
NCT01184196, a Phase 4 study, was terminated before completion, sponsored by Central DuPage Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study will enroll patients who will be receiving primary total knee replacements. Subjects will be randomized into two groups: Betadine surgical scrub preparation and ChloraPrep preparation prior to total knee replacements. Study hypothesis: When used as a surgical scrub preparation prior to primary total knee arthroplasties, ChloraPrep (2% chlorhexadine gluconate and 70% isopropyl alcohol) is superior to Betadine (10% povidone iodine) in reducing incision site bacterial colony counts.
Interventions
- DRUG Swab area with Betadine
- DRUG Swab area with ChloraPrep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01184196
The ClinicalTrials.gov registry entry for NCT01184196 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Central DuPage Hospital, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Swab area with Betadine is the first listed.
NCT01184196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01184196 about?
NCT01184196 is a clinical study titled "ChloraPrep Versus Betadine for Elective Knee Replacement Surgery". This study will enroll patients who will be receiving primary total knee replacements. Subjects will be randomized into two groups: Betadine surgical scrub preparation and ChloraPrep preparation prior to total knee replacements. Study hypothesis: When used as a surgical scrub preparation prior to p...
What is the current status of trial NCT01184196?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2009-11. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01184196?
The interventions under investigation include: Swab area with Betadine (DRUG), Swab area with ChloraPrep (DRUG).
Who is sponsoring clinical trial NCT01184196?
This trial is sponsored by Central DuPage Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.